We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Anti-Nuclear-Contamination Pill Could Help MRI Patients

By MedImaging International staff writers
Posted on 22 Sep 2019
Print article
Image: Research suggests HOPO chelators could potentially remove residual toxic gadolinium from MRI patients (Photo courtesy of Marilyn Chung/ LBL).
Image: Research suggests HOPO chelators could potentially remove residual toxic gadolinium from MRI patients (Photo courtesy of Marilyn Chung/ LBL).
A chelator drug designed to treat radiation poisoning could double as an anti-gadolinium-toxicity pill for magnetic resonance imaging (MRI) patients.

Developed at the U.S. Lawrence Berkeley National Laboratory (LBL; Berkeley, CA, USA), the chelator, a hydroxypyridinone (HOPO) ligand, is highly selective for plutonium and other actinides, but also for lanthanides such as gadolinium. The HOPO chelator is also more selective of gadolinium than conventional chelators, such as diethylenetriamine pentaacetic acid (DTPA), which binds to gadolinium, but can also bind to and deplete the body of important minerals such as calcium and zinc. In addition, if administered right before or right after an MRI, HOPO can prevent up to 96% of the gadolinium from depositing.

Gadolinium--a rare earth heavy metal--is used for enhancement during MRI. Neurotoxic effects have been seen in animals and when it is given intrathecally in humans. On its own, gadolinium can be toxic; therefore, when used in contrast agents, gadolinium is bonded with a chelating agent to control its distribution. A growing number of MRI patients have reported feeling unusual symptoms, such as joint pain, body aches, and loss of memory within days and sometimes even hours after an MRI scan. These symptoms could be linked to gadolinium, which can deposit in the bones and brains of MRI patients.

“We thought that we should investigate whether this HOPO chelator could remove gadolinium deposits from MRI patients after the contrast agent has done its job,” said Rebecca Abergel, PhD. “Our current work could help thousands of patients who rely on MRIs to have a better understanding of where a tumor might be located and whether it’s cancerous and has spread to other organs, but are concerned about the potential side effects caused by the retention of gadolinium inside the body.”

Actinides, such as uranium, plutonium, or americium, are radioactive metals with no natural biological function. However, these elements are strongly retained by most organisms and can be extremely toxic due to their radioactive and chemical properties. In the event of an accidental or ill-intentional release of nuclear material into the environment, these radionuclides pose a severe health risk as contaminants. The only practical way to reduce the dramatic health consequences of internal actinide contamination is treatment with chelating agents that form excretable complexes.

Related Links:
U.S. Lawrence Berkeley National Laboratory

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Software
UltraExtend NX
New
Brachytherapy Planning System
Oncentra Brachy
New
Portable Radiology System
DRAGON ELITE & CLASSIC

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.